Jul 292020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– SWITZERLAND, Basel – Alentis Therapeutics, the Swiss biotech developing breakthrough treatments for fibrotic diseases, today announced that Dr Roberto Iacone has been named CEO. “Alentis has developed significantly in our first year, with excellent progress in our understanding of the role of Claudin-1 as a novel therapeutic target in ...

Alentis Therapeutics appoints Dr Roberto Iacone as CEO

Alentis Therapeutics appoints Dr Roberto Iacone as CEO

From:: Alentis Therapeutics appoints Dr Roberto Iacone as CEO

Sorry, the comment form is closed at this time.